CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sinopharm Group Co Ltd Company Snapshot
Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other drug stores in Asia: Suzuken Co., Ltd. of Japan (2016 sales of 2.23 trillion Japanese Yen [US$19.94 billion] of which 93% was Pharmaceutical Wholesale Business), Alfresa Holdings Corporation of Japan (2.58 trillion Japanese Yen [US$23.06 billion] of which 88% was Wholesale Business of Pharmaceuticals fo), and Medipal Holdings Corporation which is also based in Japan (3.03 trillion Japanese Yen [US$27.10 billion] of which 70% was Pharmaceuticals And Food Precessing Whol).

Sales Analysis. During the year ended December of 2016, sales at Sinopharm Group Co Ltd were 228.67 billion Chinese Renmimbi (US$33.19 billion). This is a very small increase of 0.7% versus 2015, when the company's sales were 227.07 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd (and since 2011, sales have increased a total of 124%). Sales of Retail Pharmacy Operations saw an increase that was more than double the company's growth rate: sales were up 17.1% in 2016, from 8.71 billion Chinese Renmimbi to 10.20 billion Chinese Renmimbi. Sinopharm Group Co Ltd also saw significant increases in sales in Pharmaceutical Distribution (up 14.0% to 243.88 billion Chinese Renmimbi) . Not all segments of Sinopharm Group Co Ltd experienced an increase in sales in 2016: sales of Other Business Operations fell 1.3% to 4.30 billion Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sinopharm Group Co Ltd
  Stock Performance Chart for Sinopharm Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 29.82
(Figures in Chinese Renmimbi)
1 Week -1.6%   13 Weeks -4.2%  
4 Weeks -6.9%   52 Weeks -0.8%  
 
Sinopharm Group Co Ltd Key Data:
  Ticker: 1099 Country: China
  Exchanges: HKG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 228,672,929,000
(Year Ending Jan 2017).
Employees: 55,241
  Currency: Chinese Renmimbi Market Cap: 82,527,750,576
  Fiscal Yr Ends: December Shares Outstanding: 2,767,095,000
  Share Type: H Gu Closely Held Shares: 1,574,545,200
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.